FindMyRecallSubscribe
Class I: serious health riskTerminated

Asclemed USA Inc. dba Enovachem Dyural-40 Injection Kit Recall

Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Enovachem Pha…

Asclemed USA Inc. dba Enovachem · Torrance, CA

Risk level
Class I
Reported by FDA
Dec 26, 2018
Recall ID
D-0353-2019
Check your lot numberHow we source this data

Summary

Asclemed USA Inc. dba Enovachem recalled Dyural-40 Injection Kit starting Dec 11, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0353-2019 on Dec 26, 2018. Reason: Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex. Status: Terminated.

Why it was recalled

Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex

Product description

Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-0750-01

Lot numbers, UPCs & expiration codes

Lot #: 050518X5, 051618X1, Exp 1/31/19; 052318X4, Exp 5/1/19; 052318X5, 062818X1, 072518X3, 072718X1, 080318X2, 091818X2, Exp 5/31/19; 082318X4, 083118X1, 090518X4, 091818X4, Exp 6/30/19; 091818X3, Exp 7/31/19; 091818X5, 092418X1, 092818X4, 101018X3, 101018X5, Exp 8/31/19; 102418X5, Exp 9/30/19

Where it was sold

U.S.A. Natonwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0353-2019
Classification
Class I
Status
Terminated
Recall initiated
Dec 11, 2018
FDA report date
Dec 26, 2018
Recall type
Voluntary: Firm initiated
Recalling firm
Asclemed USA Inc. dba Enovachem

Original FDA data

Every field from FDA enforcement report D-0353-2019, exactly as published.

Show all FDA fields
City
Torrance
State
CA
Status
Terminated
Country
United States
Event ID
81741
Address
379 Van Ness Ave Ste 1403
Code information
Lot #: 050518X5, 051618X1, Exp 1/31/19; 052318X4, Exp 5/1/19; 052318X5, 062818X1, 072518X3, 072718X1, 080318X2, 091818X2, Exp 5/31/19; 082318X4, 083118X1, 090518X4, 091818X4, Exp 6/30/19; 091818X3, Exp 7/31/19; 091818X5, 092418X1, 092818X4, 101018X3, 101018X5, Exp 8/31/19; 102418X5, Exp 9/30/19
Postal code
90501-7211
Report date
Dec 26, 2018
Product type
Drugs
Recall number
D-0353-2019
Classification
Class I
Recalling firm
Asclemed USA Inc. dba Enovachem
Termination date
Feb 1, 2023
Reason for recall
Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-0750-01
Distribution pattern
U.S.A. Natonwide
Recall initiation date
Dec 11, 2018
Initial firm notification
Press Release
Center classification date
Jan 9, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0353-2019, published Dec 26, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls